Loading
Italian oncologist who led TAM-01, the trial that showed a low dose of tamoxifen halves recurrence after non-invasive breast cancer with fewer side effects than the standard dose.
Andrea DeCensi is a medical oncologist at Galliera Hospital in Genoa who has spent his career on breast cancer prevention. He was first author of the 2019 Journal of Clinical Oncology report of TAM-01, an Italian trial in which tamoxifen at 5 mg a day for three years reduced recurrence and new breast cancers after ductal carcinoma in situ and other non-invasive lesions, with a toxicity profile little different from placebo. Low-dose tamoxifen is now an option in guidelines for risk reduction.
| Title | Journal | Year |
|---|---|---|
| Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders Europe PMC author record matched by affiliation (E.O. Ospedali Galliera); 325 citations on Europe PMC. | Cancer prevention research | 2014 |
| Repurposing metformin for the prevention of cancer and cancer recurrence Europe PMC author record matched by affiliation (E.O. Ospedali Galliera); 232 citations on Europe PMC. | Diabetologia | 2017 |
| Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update Europe PMC author record matched by affiliation (E.O. Ospedali Galliera); 169 citations on Europe PMC. | Journal of Clinical Oncology | 2019 |
One of the most cited papers Europe PMC returns for Andrea DeCensi at E.O. Ospedali Galliera, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Andrea DeCensi at E.O. Ospedali Galliera, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
One of the most cited papers Europe PMC returns for Andrea DeCensi at E.O. Ospedali Galliera, so it is a natural starting point for reading their work. The record was linked automatically from the author list and affiliation; read the abstract above and the paper itself before relying on any figure.
Shares Breast cancer (all types) and the tags breast, trialist.
Shares the tags breast, trialist.
Shares the tags breast, trialist.
Shares Breast cancer (all types) and the tags breast, prevention.
Shares Breast cancer (all types) and the tags breast, prevention.
Shares Breast cancer (all types) and the tags breast, trialist.
Shares Breast cancer (all types) and the tags breast, trialist.
Shares Breast cancer (all types) and the tags breast, trialist.